Loading...
NPI 1891473203 · Portland, OR · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Laboratory Corporation Of America is a clinical medical laboratory provider located in Portland, Oregon. This profile covers 187 Medicare and 221 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Laboratory Corporation Of America |
| Address | 4400 Ne Halsey St Bldg 3 |
| City | Portland |
| State | OR |
| ZIP | 97213 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | July 6, 2023 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $3.2M |
| Medicare | $1.4M |
Payer mix is skewed toward Medicaid by scale: this provider reports $1.4M in lifetime Medicare revenue versus $3.2M in lifetime Medicaid revenue, indicating Medicaid is the larger payer relationship on file and likely drives more of the provider’s overall volume and contracting priorities. Analysts should treat Medicaid activity as the primary revenue base for local market positioning.
Medicare billing is concentrated in high-volume, routine outpatient laboratory services: the single largest Medicare code is 36415 ($187.4K, 17.2% of Medicare revenue), followed by 80053 ($122.3K, 11.2%) and 84443 ($102.5K, 9.4%), and the top three Medicare codes account for 37.8% of this provider’s Medicare revenue. This mix (venipuncture, CMP, TSH) signals an operations model centered on high-throughput sample collection and standard chemistry/endocrine testing rather than specialized molecular or esoteric assays.
Medicaid billing emphasizes sexually transmitted infection testing alongside core lab work: Medicaid top codes are 87591 ($210K, 9.0%), 87491 ($209.5K, 9.0%), and 36415 ($168.7K, 7.2%), and the top three Medicaid codes account for 25.1% of Medicaid revenue. The paired 87591/87491 volumes suggest significant NAAT-based GC/Chlamydia testing demand from clinics or public-health programs in-state.
Revenue concentration differs by payer and implies different business risks: Medicare revenue shows a tighter concentration with the top three codes representing 37.8% of Medicare revenue, whereas Medicaid’s top three represent 25.1% of Medicaid revenue. For payers and network managers this means Medicare dollars are more dependent on a small set of routine codes, while Medicaid revenue is somewhat more diversified across testing types.
Competitive standing on specimen collection and common panels is strong nationally and in-state: for Medicare 36415 ranks #116 of 86467 providers nationally (100th percentile; notably above typical national volume), and several routine panels (80053, 80061, 83036) appear in the top Medicare revenue list at very high percentiles. That ranking pattern indicates a dominant specimen-collection footprint and high absolute throughput for common lab panels at the national Medicare level.
In the state Medicaid market the provider is a leading but not singular player for STI and routine testing: 87591 and 87491 each rank #7 of 72 providers in-state (92nd percentile), while 36415 ranks #14 of 415 in-state (97th percentile; notably above typical state volume). These placements characterize the provider as a major contributor to in-state STI screening and phlebotomy services rather than a marginal participant.
Many Medicare and Medicaid line items show high absolute volume but are described as 'typical, unremarkable volume' at high percentiles (for example, 80053 and 84443 are 99th and 99th/98th percentile placements respectively), which suggests the provider’s high ranks reflect scale and broad clinical demand rather than unusual use of specialized tests. For utilization management and benchmarking, expect high claim counts across common chemistry, endocrine, and hematology panels rather than a concentration in rare/expensive assays.
Tenure on file is recent: the NPI was enumerated 2023-07-06 (~3 years ago). Analysts should consider that reported lifetime billing reflects activity since enumeration and that the provider’s current scale (large counts on routine codes) was achieved within the period following that NPI date.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
187 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 23,430 | $10 | $187.4K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 12,230 | $10 | $122.3K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 6,410 | $20 | $102.5K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 7,610 | $10 | $98.9K |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 6,400 | $10 | $64K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 2,170 | $30 | $62.9K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 7,190 | $10 | $57.5K |
| 83970 | Parathyroid hormone test measures the level of PTH in the blood. This test is done to ascertain the level of calcium and evaluate the parathyroid function. | 1,210 | $40 | $48.6K |
| 80048 | The lab analyst performs a basic metabolic pane (BMP) test in which he measures the blood level of eight chemicals including total calcium, sodium, potassium, chloride, carbon dioxide, glucose, blood… | 5,790 | $10 | $46.3K |
| 85027 | The lab analyst performs a blood count on the red and white blood cells and platelets also known as thrombocytes. He also determines the hemoglobin, typically by spectrophotometry, and the… | 6,010 | $10 | $36.1K |
Showing 1–10 of 187
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 187 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
221 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 9,550 | $20 | $210K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 9,520 | $20 | $209.5K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 56,240 | $1 | $168.7K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 29,730 | $10 | $148.6K |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 5,260 | $30 | $147.2K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 20,340 | $10 | $122.1K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 9,190 | $10 | $119.4K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 16,480 | $10 | $115.4K |
| 87389 | The lab analyst performs a test to screen for human immunodeficiency virus, called HIV. The test screens for antigens of the HIV 1 virus and antibodies to the HIV 1 and HIV 2 viruses using an… | 8,100 | $10 | $113.4K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 3,010 | $30 | $93.4K |
Showing 1–10 of 221
How this provider's Medicaid billing volume and revenue compare to other Oregon providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Oregon median
221 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 17 | 60 | 420 | $60 | $405.1K |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 4 | 20 | 780 | $30 | $360.1K |
| 99199 | Use this code to report other medicine services or procedures for which there is no specific code available. | 4 | 10 | 180 | $490 | $359.5K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 26 | 80 | 1,210 | $40 | $294.3K |
| 86003 | The lab analyst performs the technical lab test to analyze a specimen such as serum for allergen–specific immunoglobulin E (IgE), using a crude allergen extract. The test result is quantitative or… | 7 | 10 | 390 | $120 | $240.6K |
| 88175 | The lab analyst performs the technical lab test to analyze a cervical or vaginal cytopathology specimen that a clinician collected in preservative fluid. The test uses automated thin layer… | 12 | 20 | 2,750 | $20 | $205.7K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 7 | 70 | 350 | $40 | $189.7K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 7 | 70 | 350 | $40 | $189.3K |
| 87505 | The lab analyst performs a test to detect three to five types or subtypes of a pathogen, such as Clostridium difficile, E. coli, Salmonella, Shigella, norovirus, Giardia, that cause gastrointestinal… | 2 | 10 | 210 | $270 | $169K |
| 87624 | The lab analyst performs a test to determine the presence of human papillomavirus, or HPV. The provider uses nucleic acid detection for high–risk types and produces a pooled result. | 20 | 30 | 770 | $30 | $149.5K |
Showing 1–10 of 221
Other providers in the same ZIP code as Laboratory Corporation Of America, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.